Abstract
The most important issue in treatment of PJI is the correct evaluation of the patients and the decision about the appropriate treatment strategy, namely, debridement and retention, one-stage exchange, two-stage exchange, permanent resection arthroplasty, and permanent antibiotic suppression. The chosen strategy determines the final functionality and clinical results but the probability of infection cure as well. In general, more aggressive treatment results in poorer functionality but better chance of eradication of infection. This is not true for all subsets of patients. The algorithm helps to discriminate which patients would have an acceptable probability for eradication with less invasive treatment strategy. The goal is to apply the strategy that gives the best function without trading-off the probabilities of permanent infection cure too much.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AAOS (American academy of orthopedic surgeons). The diagnosis of periprosthetic joint infections in the hip or knee. Guideline and evidence report. 1st ed. Rosemont: AAOS; 2010. http://www.aaos.org/research/guidelines/guide.asp.
Berdal JE, Skramm I, Mowinckel P, Gulbrandsen P, Bjornholt JV. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect. 2005;11:834–55.
Brouqui P, Rousseau MC, Stain A, Drancourt M, Raoult D. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob Agents Chemother. 1995;39:2423–5.
Carpenter CE, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis. 2004;38:994–1000.
Ceri H, Olson ME, Stremick C. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibility of bacterial biofilms. J Clin Microbiol. 1999;37:1771–6.
Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother. 1997;39:235–40.
Dupont JA. Significance of operative cultures in total hip arthroplasty. Clin Orthop. 1986;211:122–7.
Engh CA, Massin P, Suthers KE. Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop. 1990;257:107–28.
Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W, Trampuz A. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2011;55:4821–7.
Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopedic implants. J Bone Joint Surg Am. 2001;83-a:428–36.
Isiklar ZU, Darouiche RO, Landon GC, Beck T. Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthop. 1996;332:184–9.
Kovac S, Trebše R, Milošev I, Pavlovčič V, Pišot V. Long-term survival of the straight titanium stem. J Bone Joint Surg Br. 2006;88-B:1567–73.
Meehan AM, Osmon DR, Duffy CT, Hanssen AD, Keating MR. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis. 2003;36:845–9.
Milosev I, Trebše R, Kovač S. Materials development and latest results of various bearings. In: Aoi T, Toshida A, editors. Hip replacements, approaches, complications and effectiveness. New York: Nova Science Publishers Inc; 2009.
Moojen DJ, van Hellemondt G, Vogely HC, Burger BJ, Walenkamp GH, Tulp NJ, Schreurs BW, de Meulemeester FR, Schot CS, van de Pol I, Fujishiro T, Schouls LM, Bauer TW, Dhert WJ. Incidence of low-grade infection in aseptic loosening of total hip arthroplasty. Acta Orthop. 2010;81:667–73.
Ramage G, Tunney MM, Patrick S, Gorman SP, Nixon JR. Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials. 2003;24:3221–7.
Razonable RR, Osmon DR, Steckelberg JM. Linezolid therapy for orthopedic infections. Mayo Clin Proc. 2004;79:1137–44.
Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic implants. Clin Infect Dis. 1998;27:711–3.
Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly. 2005;135:243–51.
Trampuz A, Zimmerli W. Antimicrobial agents in orthopedic surgery. Drugs. 2006;66:1089–105.
Trebše R, Pisot V, Trampuz A. Treatment of infected, retained implants. J Bone Joint Surg Br. 2005;87-B:249–56.
Trebše R. Treatment of orthopedic device related infection with device retention and defined antibiotic therapy. Thesis. University of Ljubljana, Ljubljana. 2010.
Tsukajama DT, Estrada R, Gustilo RB. Infections after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78:512–23.
Zimmerli W, Trampuž A, Ochsner P. Prosthetic joint infections. N Engl J Med. 2004;351:1645–54.
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London
About this chapter
Cite this chapter
Trebše, R., Trampuž, A. (2012). The Algorithm for Diagnostic Evaluation and Treatment. In: Trebše, R. (eds) Infected Total Joint Arthroplasty. Springer, London. https://doi.org/10.1007/978-1-4471-2482-5_23
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2482-5_23
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2481-8
Online ISBN: 978-1-4471-2482-5
eBook Packages: MedicineMedicine (R0)